Profile Core value Main business Legitimacy Social Responsibility
    Patents Research Direction Technology Strength
  API Intermediates Side chain for Paclitaxel and Docetaxel N-1 stage
  Production management QC Quality System branch factory




  Products Center
Paclitaxel (Semi-synthetic)
Paclitaxel (Natural)
Docetaxel Anhydrous
Docetaxel Trihydrate
Irinotecan HCl Trihydrate 99.5%
Etoposide USP31
Palonosetron Hydrochloride
  N-1 stage of Paclitaxel and Docetaxel
  Main Intermediates
10-Deacetylbaccatin III
Baccatin III
  Side chain for Paclixel semi-Synthetic
(4S,5R)-3-(N-benzoyl)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid
  Side chain of Docetaxel
(4S,5R)-3-(N-tert-butoxycarbony)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid
  Side chain for Paclitaxel and Docetaxel
Ethyl (2R,3S)-3-Phenylisoserine Ester
Your location:Home>>R & D >>Patents

Jinhe dedicates itself to the development of industrialization technology for Anti-cancer drugs with our own intellectual property rights. Currently Jinhe owns three patents as below:

 One of Irinotecan’s Intermediates & its Preparation method and preparation Method Of Irinotecan
Patent Number: ZL 2007 1 004 1525.X
Issue Date: Oct. 27, 2010

 A Synthetic method of Docetaxel
Patent Number: ZL 2006 1 0116735.6
Issue Date: 30 July, 2008

 A method of Extracting and Purifying 10- Deacetyl Baccatin III
Patent Number: ZL 03 1 29635.1
Issue Date: 18 May, 2005

Jinhe is actively applying other patents by its own technique, aiming at more self-developed intellectual properties to pave the way for long term development.

CopyRight(C)2006,Shanghai Jinhe Bio-Pharmaceutical Co.,Ltd. All Rights Reserved. Supported by ChemNet ChinaChemNet Toocle Copyright Notice ChemNet
HOME About us Products R & D Production and QA Contact us CHINESE
如何识破麻将作弊方法 短线的股票 山东十一选五当前遗 江苏快三官网 贵州快三中奖价格表 排列五带连线专业走势图南方版 内蒙古体彩十一选五任8 佳永配资 好运彩网站可靠吗 玻璃股票龙头 广西快三计划图